This grant is for the continued operation of the Clinical Islet Transplantation (CIT) Consortium Coordinating Center. Since 2004, the Consortium has managed eight clinical trials investigating human islets as a therapy for type 1 diabetes. This funding will support ongoing Consortium activities, enabling the completion of current studies and the preparation of vital phase III study reports. This limited competition opportunity ensures sustained progress in critical islet transplantation research, ultimately benefiting patients with type 1 diabetes by advancing potential therapeutic options.
Opportunity ID: 138053
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DK-12-501 |
| Funding Opportunity Title: | Limited Competition: Continuation of the Clinical Islet Transplantation (CIT) Consortium Data Coordinating Center (U01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Food and Nutrition Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 13, 2012 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Mar 14, 2012 |
| Current Closing Date for Applications: | Mar 14, 2012 |
| Archive Date: | Apr 14, 2012 |
| Estimated Total Program Funding: | $3,200,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) is a Limited Competition announcement for continuing the Clinical Islet Transplantation (CIT) Consortium Coordinating Center. This Consortium was begun in 2004 and has been conducting 8 clinical trials using human islets as a therapy for type 1 diabetes. This funding will support ongoing Consortium activities and allow completion of current studies and the preparation of phase III study reports. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-12-501.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| ADOBE-FORMS-B2 | ADOBE-FORMS-B2 | PKG00091730 | Feb 14, 2012 | Mar 14, 2012 | View |
Package 1
Mandatory forms
138053 RR_SF424_1_2-1.2.pdf
138053 PerformanceSite_1_4-1.4.pdf
138053 RR_OtherProjectInfo_1_3-1.3.pdf
138053 RR_KeyPersonExpanded_1_2-1.2.pdf
138053 PHS398_CoverPageSupplement_1_4-1.4.pdf
138053 PHS398_ResearchPlan_1_3-1.3.pdf
138053 PHS398_Checklist_1_3-1.3.pdf
Optional forms
138053 RR_SubawardBudget30-1.2.pdf
138053 PHS398_ModularBudget_1_2-1.2.pdf
138053 RR_Budget-1.1.pdf
138053 PHS_CoverLetter_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
